NCT00631722View on ClinicalTrials.gov

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

May 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

Quatiapine Fumarate

600-750mg/day

DRUG

Haloperidol

12-20mg/day

All Listed Sponsors
lead

Peking University

OTHER

NCT00631722 - Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia | Biotech Hunter | Biotech Hunter